Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder / Ole Köhler-Forsberg en The British Journal of Psychiatry, Año 2019 - Vol. 215 - No. 2 (Agosto)

Público ISBD [artículo]  inThe British Journal of Psychiatry > Año 2019 - Vol. 215 - No. 2 (Agosto) . - pp. 494-501 Título : Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder Tipo de documento: texto impreso Autores: Ole Köhler-Forsberg, Autor ; Erik Roj Larsen, Autor ; Henriette N. Buttenschøn, Autor Fecha de publicación: 2019 Artículo en la página: pp. 494-501 Idioma : Inglés (eng) Palabras clave: Depresión, No respondedores, Efectos secundarios, Antidepresivos, Traspuesta Resumen: For patients with major depressive disorder (MDD) experiencing side-effects or non-response to their first antidepressant, little is known regarding the effect of switching between a tricyclic antidepressant (TCA) and a selective serotonin reuptake inhibitor (SSRI). Link: ./index.php?lvl=notice_display&id=21013 [artículo] Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder [texto impreso] / Ole Köhler-Forsberg, Autor ; Erik Roj Larsen, Autor ; Henriette N. Buttenschøn, Autor . - 2019 . - pp. 494-501. Idioma : Inglés (eng) in The British Journal of Psychiatry > Año 2019 - Vol. 215 - No. 2 (Agosto) . - pp. 494-501 Palabras clave: Depresión, No respondedores, Efectos secundarios, Antidepresivos, Traspuesta Resumen: For patients with major depressive disorder (MDD) experiencing side-effects or non-response to their first antidepressant, little is known regarding the effect of switching between a tricyclic antidepressant (TCA) and a selective serotonin reuptake inhibitor (SSRI). Link: ./index.php?lvl=notice_display&id=21013

Trajectories of suicidal ideation during 12 weeks of escitalopram or nortriptyline antidepressant treatment among 811 patients with major depressive disorder / Trine Madsen en The Journal of Clinical Psychiatry, Año 2019 - Vol. 80 - No.4 (Julio - Agosto)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.4 (Julio - Agosto) . - pp. 12-18 Título : Trajectories of suicidal ideation during 12 weeks of escitalopram or nortriptyline antidepressant treatment among 811 patients with major depressive disorder Tipo de documento: texto impreso Autores: Trine Madsen, Autor ; Henriette N. Buttenschøn, Autor ; Rudolf Uher, Autor Fecha de publicación: 2019 Artículo en la página: pp. 12-18 Idioma : Inglés (eng) Palabras clave: Ideación suicida, Antidepresivos, Escitalopram, Nortriptyline, Trastorno depresivo mayor Resumen: Suicidal ideation is a frequent and difficult-to-treat clinical challenge among patients with major depressive disorder (MDD). However, little is known regarding the differential development during antidepressant treatment and whether some patients may suffer from persistent suicidal ideation. Link: ./index.php?lvl=notice_display&id=21016 [artículo] Trajectories of suicidal ideation during 12 weeks of escitalopram or nortriptyline antidepressant treatment among 811 patients with major depressive disorder [texto impreso] / Trine Madsen, Autor ; Henriette N. Buttenschøn, Autor ; Rudolf Uher, Autor . - 2019 . - pp. 12-18. Idioma : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.4 (Julio - Agosto) . - pp. 12-18 Palabras clave: Ideación suicida, Antidepresivos, Escitalopram, Nortriptyline, Trastorno depresivo mayor Resumen: Suicidal ideation is a frequent and difficult-to-treat clinical challenge among patients with major depressive disorder (MDD). However, little is known regarding the differential development during antidepressant treatment and whether some patients may suffer from persistent suicidal ideation. Link: ./index.php?lvl=notice_display&id=21016

---

1 (1 - 2 / 2)